Proliposomal intravesical paclitaxel

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameProliposomal intravesical paclitaxel
Drug Alias NamePLIPProliposomal intravesical paclitaxel - LIPAC OncologyLiPaxTBC-1002TSD-001 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMultidrug resistance protein 3 inhibitorsCytochrome P450 3A4 inhibitors
TargetsCytochrome P450 3A4Phosphatidylcholine translocator ABCB4
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTesorx PharmaLipac Oncology Llc
China Registration ClassN/A

Develop Information

Active CompaniesLipac Oncology LlcTesorx Pharma
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A